Pediatric solid tumors are a significant area of research, as they represent a unique set of challenges in cancer treatment. These tumors, which can occur in various organs such as the brain, lungs, and bones, often respond differently to therapies compared to adult cancers. Advances in treatment strategies have led to improved survival rates, but the side effects and late effects of treatment remain concerns. Research into the genetic and molecular characteristics of pediatric solid tumors has provided new targets for precision therapies, allowing for more tailored and less toxic treatment options. Ongoing clinical trials aim to further improve outcomes for these young patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States